S175 Summary: Strengthen Opioid Misuse Prevention (STOP) Act

• Extends standing orders for opioid antagonist (naloxone) to community health groups, law enforcement agencies, and nongovernmental organizations that can distribute to persons at risk of overdose and their family members or friends.

• Requires physician assistants and nurse practitioners to personally consult with supervising physicians before prescribing Schedule II-V controlled substances for long-term use (over 30 days) and at least every 90 days thereafter.

• Mandates electronic prescribing of Schedule II-V controlled substances with limited exceptions, and establishes maximum initial prescription limits of 5 days for acute pain (7 days for post-operative pain).

• Strengthens the Controlled Substances Reporting System (CSRS) by requiring dispenser and practitioner registration and use, establishing a $20 annual fee on prescribers, and creating civil penalties up to $250-$500 per pharmacy violation for improper reporting.

• Appropriates $10 million annually for fiscal years 2017-2019 to increase community-based substance use disorder treatment and recovery services, including medication-assisted treatment.